Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries

This publication has 85 references indexed in Scilit:

• Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
  The Lancet, 2011
• A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer
  International Journal of Public Health, 2010
• Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
  The Lancet Oncology, 2010
• Impact of vaccinating boys and men against HPV in the United States
  Vaccine, 2010
• Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
  British Journal of Cancer, 2010
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
  Published by Elsevier ,2009
• Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
  Vaccine, 2008
• Modeling Cervical Cancer Prevention in Developed Countries
  Vaccine, 2008
• An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
  Vaccine, 2008
• Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
  British Journal of Cancer, 2007